Sutro Biopharma(DE:S090)
€11.500.00 (0.00%)
DE:S090
Sutro Biopharma ownership
€11.50
At close:0.00 (0.00%)
Sutro Biopharma (S090) Ownership - Who Owns Sutro Biopharma?
1 Followers
Sutro Biopharma (S090) Ownership Overview
- 0.73% Insiders
- 15.65% Mutual Funds
- 60.75% Other Institutional Investors
- 10.09% ETFs
- 12.78% Public Companies and Individual Investors
The ownership structure of Sutro Biopharma (DE:S090) stock is a mix of institutional, retail, and individual investors. Approximately 86.49% of the company’s stock is owned by Institutional Investors, 0.73% is owned by Insiders, and 12.78% is owned by Public Companies and Individual Investors.
The ownership structure of Sutro Biopharma (DE:S090) stock is a mix of institutional, retail, and individual investors. Approximately 86.49% of the company’s stock is owned by Institutional Investors, 0.73% is owned by Insiders, and 12.78% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 1,178,196 | Institution | 7.10% | 14,895,932 |
| Joseph Edelman | 970,846 | Institution | 5.85% | 12,274,406 |
| Vanguard | 733,928 | Institution | 4.42% | 9,279,052 |
| Vanguard Index Funds | 678,732 | Institution | 4.09% | 8,581,209 |
| Ishares | 626,092 | Institution | 3.77% | 7,915,681 |
| Mutual Fund Series Trust | 585,262 | Institution | 3.53% | 7,399,467 |
| Tiaa-cref Funds | 355,782 | Institution | 2.14% | 4,498,152 |
| Michael Rockefeller | 350,136 | Institution | 2.11% | 4,426,769 |
| Peter Kolchinsky | 210,934 | Institution | 1.27% | 2,666,839 |
| Fidelity Salem Street Trust | 194,886 | Institution | 1.17% | 2,463,944 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 678,732 | Institution | 4.09% | 8,581,209 |
| Mutual Fund Series Trust | 585,262 | Institution | 3.53% | 7,399,467 |
| Tiaa-cref Funds | 355,782 | Institution | 2.14% | 4,498,152 |
| Fidelity Salem Street Trust | 194,886 | Institution | 1.17% | 2,463,944 |
| Goldman Sachs Trust | 157,201 | Institution | 0.95% | 1,987,492 |
| Fidelity Concord Street Trust | 113,672 | Institution | 0.68% | 1,437,155 |
| Vanguard Scottsdale Funds | 107,894 | Institution | 0.65% | 1,364,104 |
| Schwab Capital Trust | 77,471 | Institution | 0.47% | 979,466 |
| Jpmorgan Trust I | 60,304 | Institution | 0.36% | 762,423 |
| Fidelity Commonwealth Trust Ii | 49,542 | Institution | 0.30% | 626,360 |
FAQ
Who Owns Sutro Biopharma (DE:S090)?
According to the latest TipRanks data, approximately 86.49% of the company's stock is held by institutional investors, 0.73% is held by insiders, and 12.78% is held by public companies and individual investors.
What percentage of Sutro Biopharma (DE:S090) stock is held by institutional investors?
According to the latest TipRanks data, approximately 86.49% of Sutro Biopharma (DE:S090) stock is held by institutional investors: 15.65% by mutual funds, 10.09% by ETFs and 60.75% by other institutional investors.
What percentage of Sutro Biopharma (DE:S090) stock is held by retail investors?
According to the latest TipRanks data, approximately 12.78% of Sutro Biopharma (DE:S090) stock is held by public companies and individual investors.
Who owns the most shares of Sutro Biopharma (DE:S090)?
BlackRock, Inc. owns the most shares of Sutro Biopharma (DE:S090).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

